Context: Failure of passive transfer of immunity due to insufficient and/or delayed administration of good quality colostrum is a risk for disease, death and reduced weight gain in lambs.
Objective: This trial evaluated the performance and health of lambs fed a bovine source lacteal derived colostrum powder in addition to farm colostrum compared to two feedings of farm colostrum.
Setting: This trial was performed on a large commercial sheep farm in Israel in 2015.
Participants: Two cohorts, a total of 60 male lambs, were enrolled at birth and followed until sent to market at approximate 5.5 months of age.
Interventions: The lambs randomly assigned at birth to receive either 250 ml of a bovine colostrum replacement (CR) or 250 ml of farm source ewe colostrum (FC) within half an hour of birth. Within 6 hours of birth a second feeding of 250 ml of farm source ewe colostrum was administered to both groups.
Main outcome measures: Colostral Brix% and serum brix% was measured using a Brix digital refractometer and compared between treatments. Morbidity, mortality and weight gain was recorded until marketing at average 165 days of age and compared between treatments.
Results: The Brix values were significantly higher in CR compared to FC. Serum% Brix was significantly higher in CR than FC lambs. There was significantly less disease in CR lambs (0%) than in FC lambs (17%) (P=0.05). Significantly more CR lambs (97%, 29 of 30 lambs) were marketed compared to FC lambs (77%, 23 of 30 lambs) (P=0.05). Conclusions: The use of this commercial colostrum replacement may facilitate colostrum management and improve health and productivity in lambs.
Berge AC, Hassid G, Leibovich H, Solomon D, Haines DM, Chamorro MF
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : December 14, 2018